Wellington Global Hlthcr Eq GBP T Ac |
Performance History | 31/03/2024 |
Growth of 1,000 (EUR) |
Fund | 16.1 | 11.6 | -4.0 | 3.5 | 8.6 | |
+/-Cat | 4.9 | -5.0 | 5.8 | 4.3 | 1.9 | |
+/-Idx | - | -14.4 | -4.1 | 3.7 | -0.9 | |
Category: Sector Equity Healthcare | ||||||
Benchmarks: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 19/04/2024 | GBP 100.08 | |
Day Change | -0.18% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B39YK708 | |
Fund Size (Mil) 19/04/2024 | USD 2421.84 | |
Share Class Size (Mil) 19/04/2024 | GBP 15.25 | |
Max Initial Charge | - | |
Ongoing Charge 14/03/2024 | 0.08% |
Investment Objective: Wellington Global Hlthcr Eq GBP T Ac |
The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Rebecca Sykes 30/06/2022 | ||
Inception Date 07/07/2008 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Wellington Global Hlthcr Eq GBP T Ac | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.79 |
UnitedHealth Group Inc | Healthcare | 6.58 |
Merck & Co Inc | Healthcare | 5.40 |
AstraZeneca PLC | Healthcare | 3.70 |
Novartis AG Registered Shares | Healthcare | 3.35 |
Increase Decrease New since last portfolio | ||
Wellington Global Hlthcr Eq GBP T Ac |